Nestlé will retain its Health Science business
In an interview on Sunday, Nestlé Chairman Paul Bulcke firmly stated that the company has no plans to sell its Health Science business, which some analysts had previously speculated could be sold in the medium term. Asked by NZZ am Sonntag, Bulcke confirmed: “Of course” they will keep this division, which he called promising and beneficial to society.
The statement came shortly after Nestlé announced the replacement of CEO Mark Schneider, who is stepping down after nearly eight years in the role. He will be replaced by company veteran Laurent Freixe. Schneider’s departure has led some analysts to speculate about the possibility of a sale of the Health Science business, which would have been a positive move for investors, especially in light of the decline in Nestlé shares since May 2023.
However, Bulcke emphasized that Schneider’s departure was not due to the development of stock prices, and that they remain committed to keeping the Health Science business, which represents significant strategic value for the company.
Related news
Retail kept its position in terms of employer attractiveness
Honouring Hungary’s most attractive employers, the Randstad Awards have been…
Read more >Nestlé Announces Global Roll-Out Of Sinergity
Food giant Nestlé has announced the global launch of Sinergity,…
Read more >Nestlé invests in Zimbabwe cereal manufacturing plant
The “strategic upgrade” includes the addition of a fourth roller…
Read more >Related news
KSH: in April, retail turnover exceeded the same period of the previous year by 5.0 percent and the previous month by 2.0 percent
In April 2025, the volume of retail trade turnover increased…
Read more >FAO food price index fell in May
The benchmark global food price index fell in May from…
Read more >Eurozone retail sales rise in April
Retail sales in the eurozone and the European Union increased…
Read more >